Company Filing History:
Years Active: 2009-2019
Title: Mark Smith: Innovator in Modified Nucleotides
Introduction
Mark Smith is a distinguished inventor based in Nr Saffron Walden, GB. He has made significant contributions to the field of biochemistry, particularly in the development of modified nucleotides. With a total of 7 patents to his name, Smith's work has the potential to impact various applications in genetic research and therapeutics.
Latest Patents
One of Smith's latest patents focuses on modified nucleotide or nucleoside molecules. This invention provides a structure that includes a purine or pyrimidine base and a ribose or deoxyribose sugar moiety. The molecule features a removable 3'-OH blocking group covalently attached, allowing for various chemical modifications. The invention outlines a method for reacting the molecule to yield intermediates that can be further processed, showcasing Smith's innovative approach to nucleotide chemistry.
Career Highlights
Smith is currently employed at Illumina Cambridge Limited, a company renowned for its advancements in genomic sequencing technologies. His role at Illumina allows him to collaborate with leading experts in the field, further enhancing his contributions to biochemistry and molecular biology.
Collaborations
Some of Smith's notable coworkers include John Milton and Xiaolin Wu. Their collaborative efforts contribute to a dynamic research environment that fosters innovation and the development of groundbreaking technologies.
Conclusion
Mark Smith's work in modified nucleotides exemplifies the intersection of innovation and practical application in biochemistry. His contributions continue to pave the way for advancements in genetic research and therapeutic development.